Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

NCT00268255 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never moved forward with accrual.

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: gefitinib
PROCEDURE: adjuvant therapy
PROCEDURE: enzyme inhibitor therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: protein tyrosine kinase inhibitor therapy
PROCEDURE: radiation therapy
PROCEDURE: radiosensitization

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]